Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer.
Saved in:
| Title: | Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. |
|---|---|
| Authors: | Xu X; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Sun XY; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Chang M; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Hu ZL; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Cheng TT; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Hang TJ; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Song M; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China. |
| Source: | Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 1298-1309. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print Cited Medium: Internet ISSN: 1744-5116 (Electronic) Linking ISSN: 13880209 NLM ISO Abbreviation: Pharm Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-5116 |
|---|---|
| DOI: | 10.1080/13880209.2023.2246500 |
